Developing safe and effective gene delivery platforms to unlock the therapeutic power of personalized, redoseable genetic medicine.
Mediphage Bioceuticals's investors include Wing Venture Capital, Creative Destruction Lab, Viking Global Investors, UK Research and Innovation, National Research Council of Canada Industrial Research Assistance Program.
Mediphage Bioceuticals is headquartered in Toronto, Canada.
Developing safe and effective gene delivery platforms to unlock the therapeutic power of personalized, redoseable genetic medicine.
Mediphage Bioceuticals is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mediphage Bioceuticals — Funding & Investors." VCBacked, January 6, 2026, https://www.vcbacked.co/company/mediphage-bioceuticals. Accessed August 15, 2026.
VCBacked. (2026). Mediphage Bioceuticals — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/mediphage-bioceuticals
{{cite web |title=Mediphage Bioceuticals — Funding & Investors |url=https://www.vcbacked.co/company/mediphage-bioceuticals |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated